Evidence map›Paper›PMID 28549485›Full record

ArticleBMC infectious diseases2017

An assessment of the geographical risks of wild and vaccine-derived poliomyelitis outbreaks in Africa and Asia.

Kathleen M O'Reilly, Christine Lamoureux, Natalie A Molodecky, Hil Lyons, Nicholas C Grassly, Graham Tallis

Abstract read
In one paragraph

Article in BMC infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kathleen M O'ReillyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, St Mary's Campus, Imperial College London, London, UK. k.oreilly@imperial.ac.uk.
Christine LamoureuxWorld Health Organization, Geneva, Switzerland.
Natalie A MolodeckyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, St Mary's Campus, Imperial College London, London, UK.
Hil LyonsInstitute for Disease Modelling, Seattle, USA.
Nicholas C GrasslyMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, St Mary's Campus, Imperial College London, London, UK.
Graham TallisWorld Health Organization, Geneva, Switzerland.

Funding

Medical Research Council MR/J014362/1World Health Organization 001
6 · The paper itself

Abstract

backgroundThe international spread of wild poliomyelitis outbreaks continues to threaten eradication of poliomyelitis and in 2014 a public health emergency of international concern was declared. Here we describe a risk scoring system that has been used to assess country-level risks of wild poliomyelitis outbreaks, to inform prioritisation of mass vaccination planning, and describe the change in risk from 2014 to 2016. The methods were also used to assess the risk of emergence of vaccine-derived poliomyelitis outbreaks.

methodsPotential explanatory variables were tested against the reported outbreaks of wild poliomyelitis since 2003 using multivariable regression analysis. The regression analysis was translated to a risk score and used to classify countries as Low, Medium, Medium High and High risk, based on the predictive ability of the score.

resultsIndicators of population immunity, population displacement and diarrhoeal disease were associated with an increased risk of both wild and vaccine-derived outbreaks. High migration from countries with wild cases was associated with wild outbreaks. High birth numbers were associated with an increased risk of vaccine-derived outbreaks.

conclusionsUse of the scoring system is a transparent and rapid approach to assess country risk of wild and vaccine-derived poliomyelitis outbreaks. Since 2008 there has been a steep reduction in the number of wild poliomyelitis outbreaks and the reduction in countries classified as High and Medium High risk has reflected this. The risk of vaccine-derived poliomyelitis outbreaks has varied geographically. These findings highlight that many countries remain susceptible to poliomyelitis outbreaks and maintenance or improvement in routine immunisation is vital.

Indexed as

AfricaAsiaDisease OutbreaksHumansMass VaccinationPoliomyelitisPoliovirusPoliovirus VaccinesPublic HealthRisk AssessmentSpatio-Temporal AnalysisPoliovirus VaccinesMigrationOutbreakPoliomyelitisRegressionRisk assessmentRoutine immunisationVaccinationVaccine-derived

Identifiers

PMID28549485
PMCPMC5446690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.